Cardiology Today Current Issue

The following articles appeared in the print edition of Cardiology Today.

Table of Contents

• CVD prevention, treatment challenging as patients with HIV and HCV live longer Erik Swain
• FDA approves blood pump system for patients undergoing high-risk PCI
• FDA approves ivabradine for treatment of HF
• FDA grants priority review for investigational HF treatment
• FDA panel backs approval of cangrelor
• FDA: Use of TAVR system expanded to include aortic valve-in-valve replacement
• New administration option for ticagrelor now approved
• A tribute to Elijah Saunders, MD Roger S. Blumenthal, MD; Michael Miller, MD, FACC, FAHA
• Cardiology Today Editorial Board gathers at ACC 2015
• Mutations in NR2F2 can induce atrioventricular defects, LV outflow tract obstruction Robert Roberts, MD, FRSC, FRCPC, MACC, LLD (Hon.), FAHA; Calvin W. Roberts, MD; William L. Roberts, MHA, CPA; Brandon A. Roberts, MSc, MD
• ACP advises against CHD screening in low-risk patients
• Consensus statement provides new guidance on minimally invasive valve treatments for children, adults
• ED visits for ischemic stroke, TIA declined in past decade
• Expert consensus statement addresses expanding options for percutaneous mechanical support devices
• Genetically determined shorter height linked with increased risk for CAD
• HF patients with functional disability at higher risk for hospitalization, early death
• LEADLESS published: Lead-free cardiac pacemaker shows good safety, performance at 1 year
• Lower-extremity revascularization common, but may be ineffective for nursing home residents with PAD
• Mood disorders, sex, age linked to inaccurate patient perception of AF burden
• Number of births may affect atherosclerosis risk in women
• Number of donor hearts accepted for transplant declines in US
• Odds of major bleeding, mortality lower with fondaparinux than heparin
• Pre-frailty raises risk for CVD in older adults
• High-dose statins mitigate association between elevated phospholipids, MACE in patients with stable CAD
• Sudden cardiac arrest very low in middle-aged adults during physical activity
• Transcutaneous low-level tragus electrical stimulation suppresses AF
• SPYRAL HTN program to evaluate renal denervation for uncontrolled hypertension
• Ablation improves rhythm control in mitral valve surgery
• Ablation superior to amiodarone for treatment of persistent AF in patients with HF
• Novel anticoagulation system had similar CV outcomes to bivalirudin, linked to increased bleeding, allergic reactions
• CASCADE-FH Registry: Patients lack awareness of familial hypercholesterolemia
• EMBRACE-STEMI: Drug targeting mitochondria does not reduce infarct size
• ERRICA: Remote ischemic preconditioning fails to improve CABG outcomes
• Excess sedentary time raises risk for coronary artery calcification
• Folic acid supplementation reduces stroke risk
• Harrington reflects on past, future of NSTEACS research
• IMPROVE-IT: Ezetimibe plus simvastatin reduces total, recurrent CV events
• MATRIX: In patients with ACS needing angiography, access site matters but anticoagulant might not
• Oral anticoagulants underused for stroke prevention in patients with nonvalvular AF
• First report of US commercial data for transcatheter mitral valve repair system shows favorable outcomes
• Self-expanding TAVR system superior to surgery in high-risk patients at 2 years
• A look at coagulation assays for target-specific oral anticoagulants Shreya Patel, PharmD, BCPS; Eyerusalem Befkadu, PharmD candidate; Sarah A. Spinler, PharmD, FCCP, FAHA, FASHP, AACC, BCPS (AQ Cardiology)
• Trial Scorecard: BEST
• Trial Scorecard: EMBRACE-STEMI
• Trial Scorecard: ERICCA
• Trial Scorecard: MATRIX
• Trial Scorecard: NOTION
• Trial Scorecard: OSLER
• Trial Scorecard: RECESS
• Trial Scorecard: REVASCAT